Clinical Trial Update: Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants [Phase 3]

View source ↗

Summary

Phase 3 trial comparing DTaP-IPV-HB-PRP-T (Sanofi Pasteur) to Infanrix Hexa when co-administered with Prevnar in Thai infants; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Poliomyelitis

Drugs mentioned

• DTaP-IPV-HB-PRP-T
• Infanrix Hexa (DTPa-HBV-IPV/Hib)
• Prevnar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Hepatitis B, Polio | Phase 3 | Status: COMPLETED | Results posted: 2014-04-01